Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Empaveli for PNH

May 17, 2021

FDA authorizes Pfizer and BioNTech's COVID-19 vaccine for adolescents aged 12-15 years

May 11, 2021

China NMPA approves bevacizumab biosimiilar LY-01008

May 10, 2021

China NMPA grants conditional approval to pamiparib for advanced ovarian cancer

May 7, 2021

European Commission approves Sibnayal for distal renal tubular acidosis

May 5, 2021

FDA approves Farxiga for chronic kidney disease

May 3, 2021

FDA grants accelerated approval to Zynlonta for relapsed or refractory large B-cell lymphoma

April 26, 2021

FDA grants accelerated approval to Jemperli for dMMR endometrial cancer

April 23, 2021

Trodelvy gains accelerated approval in U.S. for advanced urothelial cancer

April 14, 2021

Toripalimab approved in China for locally advanced or metastatic urothelial carcinoma

April 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 4, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
Checkpoint inhibitor journey traces Chinese firms’ path to global revenue
BioWorld
Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...